Episode 117 - Raj Devraj - CEO Rectify Pharma episode artwork

EPISODE · Feb 11, 2026 · 35 MIN

Episode 117 - Raj Devraj - CEO Rectify Pharma

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

In this episode of The BioHub, I’m joined by Raj Devraj, CEO of Rectify Pharma and Venture Partner at Atlas Venture.Raj has spent his career building biotech companies around bold science, including co-founding Disarm Therapeutics, which was acquired by Eli Lilly. Now he’s doing it again with Rectify.We talk about starting companies from zero, building the right teams early, de-risking new ventures, and the realities of fundraising in today’s biotech market. A practical, honest conversation with a true biotech builder.

Episode metadata supplied by the publisher feed · Published Feb 11, 2026

Embed this episode

NOW PLAYING

Episode 117 - Raj Devraj - CEO Rectify Pharma

0:00 35:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 35 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on February 11, 2026.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!